Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression

Acta Neuropathol. 2017 Dec;134(6):961-963. doi: 10.1007/s00401-017-1780-0. Epub 2017 Oct 23.

Giselle Y Lopez¹, Nancy Ann Oberheim Bush², Joanna J Phillips^{1

3}, John-Paul Bouffard⁴, Yaron A Moshel^{5

6}, Kurt Jaeckle⁷, B K Kleinschmidt-DeMasters⁸, Marc K Rosenblum⁹, Arie Perry^{1

3}, David A Solomon^{10

11}

¹ Division of Neuropathology, Department of Pathology, University of California, San Francisco, 513 Parnassus Ave, Health Sciences West 451, Box 0102, San Francisco, CA, 94143, USA.
² Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, CA, USA.
³ Department of Neurological Surgery, University of California, San Francisco, CA, USA.
⁴ Department of Pathology, Overlook Medical Center, Summit, NJ, USA.
⁵ Atlantic Neurosurgical Specialists, Summit, NJ, USA.
⁶ Department of Neurosurgery, NYU Langone Medical Center, New York, NY, USA.
⁷ Department of Neurosciences, Atlantic Health System, Summit, NJ, USA.
⁸ Departments of Pathology, Neurology, and Neurosurgery, University of Colorado, Aurora, CO, USA.
⁹ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁰ Division of Neuropathology, Department of Pathology, University of California, San Francisco, 513 Parnassus Ave, Health Sciences West 451, Box 0102, San Francisco, CA, 94143, USA. [email protected].
¹¹ Clinical Cancer Genomics Laboratory, Department of Pathology, University of California, San Francisco, CA, USA. [email protected].

No abstract available

Publication types